Speaker illustration

Professor Andrew Stewart Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients

Event: ESC Congress 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session type: Satellite Symposium

Thumbnail

Heart failure and secondary mitral regurgitation: all you need to know

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Symposium

Thumbnail

Personalized approach in real-world heart failure management: are we ready for the revolution?

Event: ESC Congress 2022

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Cardiac contractility modulation: a proven device-based therapeutic approach to reduce hospitalizations and improve quality of life for patients with heart failure

Event: ESC Congress 2022

Topic: Device Treatment

Session type: Satellite Symposium

Thumbnail

Heart Failure 2022 highlights

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

Lifetime Achievement Award 2022

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

The year's best papers on heart failure

Event: Heart Failure 2022

Topic: Heart Failure Association (HFA)

Session type: Special Session

Thumbnail

Optimizing foundational therapies in patients with heart failure: from evidence to real-world clinical practice

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

A new era for HFpEF – Exploring the role of empagliflozin in practice

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

Late-Breaking Trials - Pharmacological treatment I

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb